Kirloskar Indus. (KIRLOSIND)

FairStock Score: 9/100 — RISKY

Score breakdown: P/E: 2/3 · ROCE: 0/2 · Growth: 1/2 · Dividend: 0/1

Key Financials

Strengths

• Trades at 0.58x book value with BVPS of ₹5,579.23 versus price of ₹3,254.40, offering a potential margin of safety.
• Low leverage: Debt/Equity of 0.15 and Piotroski F-Score of 7/9 indicate a sound balance sheet.
• High promoter holding of 71.87% aligns management with long-term ownership.
• Latest quarter sales of ₹1,624 Cr and net profit of ₹49 Cr show positive, if modest, operating performance.

Concerns

• Very low ROE of 1.47% and ROCE of 6.72% mean the business is earning poor returns on its large book value.
• Sales growth of only 0.64% shows top-line stagnation.
• P/E of 18.49 combined with PEG of 3.97 suggests the stock is not cheap on earnings growth; FairStock Score of 13/100 flags risk.
• Dividend yield of just 0.46% offers little income while waiting for value to be unlocked.

AI Analysis

I approach Kirloskar Industries the way Graham taught me: measure the asset, then judge the earning power. At ₹3,254.40, the stock trades at only 0.58 times book value of ₹5,579.23 per share. That discount grabs attention. But a cheap price is meaningless if the business behind it cannot earn an attractive return. Here, ROE is just 1.47% and ROCE is 6.72%. This is not a wonderful business; it is a balance sheet with a modest earnings engine. Sales growth of 0.64% is essentially flat, and profit growth of 5.99% is far too slow to justify a P/E of 18.49. The PEG ratio of 3.97 confirms the market is paying up for very little growth. On the positive side, debt-to-equity is only 0.15, and a Piotroski score of 7/9 indicates the financial position is sound. There is no immediate solvency risk. But as a minority shareholder, I need returns from either earnings or dividends. A dividend yield of 0.46% is barely compensation for waiting. Promoter holding at 71.87% gives management control, but that also means minority shareholders depend on their capital allocation discipline. The latest quarter shows sales of ₹1,624 crore and net profit of ₹49 crore—decent, but not spectacular. This looks like an asset play, not a compounder. I would only buy if I believed management could meaningfully improve returns on that rich book value or unlock it through dividends and buybacks. Until then, the low P/B ratio is a trap, not a bargain.

Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer